Journal of the American Society of Nephrology· 2018Q1
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation
- 245citations
- Q1SCImago
- 2018year
Short summary
Everolimus with reduced calcineurin inhibitor (CNI) exposure was noninferior to mycophenolic acid (MPA) with standard CNI exposure in kidney transplant recipients at mild-to-moderate immunologic risk, failing to meet the primary composite endpoint of acute rejection or poor graft function (48.2% vs 45.1%).
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Transplantation
TransplantationMedicine